Over One Billion NTD Treatments Supported By ENVISION
ENVISION operated in strong coordination with the largest public-private partnerships in USAID’s history, supporting the distribution of $16.2 billion worth of donated medicines from major pharmaceutical companies dedicated to fighting NTDs. In the countries we supported, ENVISION has provided more than 1.4 billion NTD treatments.
Due to the substantial investment made by national NTD programs, USAID, drug donation programs, and other partners, multiple ENVISION-supported countries have achieved a dramatic reduction of the most common NTDs. At ENVISION’s close, more than 230 million people were no longer at risk of lymphatic filariasis and more than 86 million people had been spared from the risk of trachoma.Indeed, many ENVISION-supported countries have seen incredible success—Cambodia and Vietnam have now been validated by the World Health Organization (WHO) as having eliminated lymphatic filariasis (LF), and Cambodia, Laos, and Nepal are validated as having eliminated trachoma.
Learn more about the ENVISION Impact in the Final Report.